SLAMF7: CAR T

Caterina Alati1,2, Martina Pitea1,2, Gaetana Porto1,2

  • 1Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", 89133 Reggio Calabria, Italy.

Cancers
|November 13, 2025
PubMed
概括

信号淋巴细胞激活分子家族成员7 (SLAMF7) 是对抗多发性骨髓瘤 (MM) 的CAR-T细胞治疗的有希望的标. 需要工程解决方案来防止在针对SLAMF7.7时进行CAR T细胞兄弟杀戮.